Orange Book product · Generic (ANDA)
TRETINOIN
TRETINOIN
At a glance
Oct 24, 2012
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 24, 2012
13 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
TRETINOIN
Strength
10MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 201687
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of TRETINOIN
- 2018ALTRENOBrand (NDA)
NDA 209353 · DOW PHARM
- 2007ATRALINBrand (NDA)
NDA 022070 · DOW PHARM
- 2002RETIN-A MICROBrand (NDA)
NDA 020475 · BAUSCH
- 2000RENOVABrand (NDA)
NDA 021108 · VALEANT PHARMS NORTH
- 1998AVITABrand (NDA)
NDA 020400 · RISING
- 1997AVITABrand (NDA)
NDA 020404 · MYLAN PHARMS INC
- 1995RENOVABrand (NDA)
NDA 019963 · VALEANT PHARMS NORTH
- 1995VESANOIDBrand (NDA)
NDA 020438 · CHEPLAPHARM
- 1988RETIN-ABrand (NDA)
NDA 019049 · BAUSCH
- —RETIN-ABrand (NDA)
NDA 017522 · VALEANT BERMUDA
- —RETIN-ABrand (NDA)
NDA 017340 · VALEANT PHARMS NORTH
- —RETIN-ABrand (NDA)
NDA 017955 · BAUSCH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
